PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
April 11, 2013 | ISSUE NUMBER 294 VOL 10

Regulatory
"Sunshine" Just the Tip of the Iceberg: Pharma and Full Disclosure
Although recent legislation and regulations have greatly expanded the range of information that pharmaceutical companies have to unveil to the public, there’s an escalating demand for even more transparency. The new “Sunshine” law is just the tip of the iceberg, writes Jill Wechsler ...Read more

Cegedim Relationship Management
Study Discovers 89% Will Utilize an Automated Reporting Solution for Sunshine Act Compliance; Nearly 60% Plan to Use a Third-party Solution.
Cegedim Relationship Management's 2013 US Trends in Aggregate Spend and Disclosure Report provides a comprehensive overview of how increased transparency is affecting US pharmaceutical and medical device industries, including the affect of the Sunshine Act. 
To read more, download the complimentary report today.

Med Tech
Repeal of Medical Devices Tax Still Faces Significant Hurdles
On March 21, the US Senate approved an amendment by a vote of 79 to 20 to repeal the 2.3 percent medical device excise tax. Despite the vote, it is far from clear that repeal of the tax will occur, writes William Kitchens ...Read More

CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
www.bioworld.com

Healthcare Reform
Drug Utilization Under Managed Medicaid
Cash-strapped states are shifting patients from traditional fee-for-service Medicaid coverage to managed Medicaid plans. The IMS Institute of Healthcare Informatics took an early look at how this trend effects prescription drug utilization

...Read more

New Models of Cancer Research in the Age of Personalized Medicine
Live Webcast: Wednesday, April 17, 2013 at 11:00 am EDT
Register Free at: www.pharmexec.com/personalized

Sales & Marketing
Mapping Opportunities with the Non-Physician Prescriber
They write 92% of their prescriptions without consulting a physician and are often the first provider a patient sees, and yet nurse practitioners, physician’s assistants and other non-physician prescribers (NPPs) are still somehow overlooked by pharma as an opportunity to drive sales
...Read more

Adherence
The Pharma Marketer's Guide to Medication Adherence
Grant Corbett previews the upcoming Patient Adherence and Support Summit event in Philadelphia (April 29-30), at which brand directors and marketers will have a unique opportunity to hear senior VP's, consultants and academic researchers provide their perspectives on what to target in 2013
...Read more

Product Management
The Successful Product Manager’s Handbook
Learn how to create a brand positioning statement, build brand value and turn business information into action. Strategy game planning — a competitive intelligence tool for pharma brand and product managers. Get tips on creating an effective launch plan
...Read more

// Teva appointed new CEOs to two of its subsidiaries in Asia. Yoo Suk Hong, formerly CEO of Lilly Korea, becomes the first CEO of Teva-Handok in Korea; Ichiro Kikushige, formerly Senior Director of Sales for Lilly Japan, becomes President and CEO of Teva Seiyaku in Japan. // Rib-X Pharmaceuticals (New Haven CT) announced new appointments to the executive team and Board of Directors. Mary Szela was appointed Chief Executive Officer (she will remain a director; Eugene Sun, MD, was appointed Executive Vice President, Research and Development; Michael Kenston became Chief Commercial Officer; and Thomas Koestler, PhD, was appointed Chairman of the Board.//

April 29–30: 12th Annual Patient Adherence and Support Summit
Philadelphia, PA.


May 6–7: CBI’s 10th Forum on Patient Reported Outcomes
Philadelphia, PA.


May 21–22: Regulatory Submission and Reporting Strategies
Washington, DC.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin


Survey
How optimistic are you about your company achieving revenue growth in 2013?

Click To Vote
Quick Links

The Keys to Success in Personalized Medicine

Are US and Canadian Rx Policies Converging?

Understanding the New Key Account Management Culture